- Home
- SRV vs ADCT Comparison
SRV vs ADCT Comparison
Compare SRV & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRV
- ADCT
- Stock Information
- Founded
- SRV 2007
- ADCT 2011
- Country
- SRV United States
- ADCT Switzerland
- Employees
- SRV N/A
- ADCT N/A
- Industry
- SRV Finance Companies
- ADCT Biotechnology: Pharmaceutical Preparations
- Sector
- SRV Finance
- ADCT Health Care
- Exchange
- SRV Nasdaq
- ADCT Nasdaq
- Market Cap
- SRV N/A
- ADCT 143.1M
- IPO Year
- SRV N/A
- ADCT 2020
- Fundamental
- Price
- SRV $44.08
- ADCT $1.33
- Analyst Decision
- SRV
- ADCT Strong Buy
- Analyst Count
- SRV 0
- ADCT 5
- Target Price
- SRV N/A
- ADCT $7.75
- AVG Volume (30 Days)
- SRV 33.9K
- ADCT 349.4K
- Earning Date
- SRV 01-01-0001
- ADCT 03-27-2025
- Dividend Yield
- SRV 13.38%
- ADCT N/A
- EPS Growth
- SRV N/A
- ADCT N/A
- EPS
- SRV N/A
- ADCT N/A
- Revenue
- SRV N/A
- ADCT $70,837,000.00
- Revenue This Year
- SRV N/A
- ADCT $11.56
- Revenue Next Year
- SRV N/A
- ADCT $17.03
- P/E Ratio
- SRV N/A
- ADCT N/A
- Revenue Growth
- SRV N/A
- ADCT 1.84
- 52 Week Low
- SRV $30.73
- ADCT $1.28
- 52 Week High
- SRV $44.30
- ADCT $5.38
- Technical
- Relative Strength Index (RSI)
- SRV 49.39
- ADCT 33.16
- Support Level
- SRV $43.00
- ADCT $1.28
- Resistance Level
- SRV $44.90
- ADCT $1.68
- Average True Range (ATR)
- SRV 0.86
- ADCT 0.11
- MACD
- SRV 0.11
- ADCT -0.04
- Stochastic Oscillator
- SRV 54.08
- ADCT 8.40
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.